含不同个数基序乳酸乳球菌肽聚糖锚钩蛋白结合活性比较

【目的】比较两种含不同个数基序乳酸乳球菌肽聚糖锚钩蛋白(protein anchor,PA)的结合活性。【方法】首先应用PCR技术分别扩增得到含有2个或3个自溶素基序(Lysin Motif,Lys M)基因片段的PA2与PA3;然后应用p ET-32a(+)质粒构建原核表达载体,将其转化大肠杆菌BL-21(DE3),进行诱导表达,获得目的蛋白;最后将经复性后的PA2、PA3融合蛋白与GEM(Gram-positive Enhancer Matrix,GEM)颗粒结合,经Western blot、透射电镜与SDS-PAGE进行结合鉴定与结合活性比较分析。【结果】融合蛋白PA2、PA3复性后都能与GEM结合,PA3与GEM颗粒的结合活性明显好于PA2。【结论】含有3个Lys Ms的PA对GEM的结合活性明显优于含有2个Lys Ms的PA。本研究可为进一步完善乳球菌外壳-蛋白锚钩展示系统提供理论基础。     

带锚定基序3LysM的EGFP融合蛋白与乳酸乳球菌的体外混合展示

目的探索融合有锚定序列的EGFP蛋白,能否通过体外混合展示于乳酸乳球菌MG1363表面。方法采用融合PCR方法扩增带有锚定序列的egfp(3LysM-egfp),亚克隆至pMD18T载体,测序正确后,插入表达载体pET28a转化BL21(DE3)进行诱导表达、纯化,将纯化的3LysM-EGFP与乳酸乳球菌进行体外混合作用,荧光显微镜及Western-blot检测展示效果。结果成功构建表达重组菌pET28a-3LysM-egfp/BL21并诱导出可溶性3LysM-EGFP,纯化后蛋白纯度达到81.5%,荧光显微镜及Western-blot均检测到展示的目的蛋白。结论纯化后的3LysM-EGFP能在体外条件下展示在乳酸乳球菌表面。     

基于谷氨酸棒杆菌NCgl1221蛋白的新型细菌表面展示系统

【目的】开发一种新型的大肠杆菌表面展示系统,为C末端截短NCgl1221蛋白作为锚定蛋白提供科学依据,丰富并优化细菌表面展示系统。【方法】扩增C末端截短NCgl1221序列和β-淀粉酶基因,构建融合蛋白表达载体。将重组载体PET-NA和空载体PET-28a分别转入Rosetta(DE3)pLysS中,IPTG诱导表达,SDS-PAGE和Western blot鉴定融合蛋白表达情况。将诱导表达菌株进行免疫荧光染色,荧光显微镜观察和流式细胞分析检测β-淀粉酶的展示。酶活测定和淀粉水解分析验证被展示β-淀粉酶的活性。【结果】融合蛋白成功地在大肠杆菌中表达,有活性的β-淀粉酶通过与锚定蛋白C末端的融合被展示在了宿主菌表面,展示β-淀粉酶的重组菌可以水解利用培养基中的淀粉。【结论】成功开发了一种以C末端截短NCgl1221为锚定蛋白的新型大肠杆菌表面展示系统,并以此系统展示了分子量大小为56 kDa的活性酶,为该系统在全细胞催化剂或吸附剂等方面的应用奠定了基础。     

产单核细胞李斯特菌p60蛋白N端肽聚糖结合基序在枯草芽孢杆菌中的表达

目的:构建产单核细胞李斯特菌胞外蛋白p60的N端肽聚糖结合基序(p60-N)表达载体,实现其在枯草芽孢杆菌中的分泌表达。方法:将目标基因克隆到表达载体pHT43中获得重组载体pHT43-p60-N,转化枯草芽孢杆菌WB800N获得重组工程菌株WB800N/pHT43-p60-N,在此基础上考察IPTG浓度、培养基、表达时间和温度等条件对目标蛋白表达的影响。结果:p60-N蛋白可在枯草芽孢杆菌中分泌表达,与鼠李糖乳杆菌形成的革兰阳性增强基(GEM)颗粒特异性结合,具有与天然蛋白类似的生物学活性。用GB培养基,在37℃下,加入终浓度为0.2 mmol/L的IPTG诱导12~20 h,表达量提高到28 mg/L。结论:实现了p60蛋白N端基序在枯草芽孢杆菌中的分泌表达,为进一步研究以该蛋白为基础的细菌样颗粒疫苗奠定了基础。     

基于冰核蛋白的乳酸菌表面展示系统的构建

[目的]验证来源于丁香假单胞菌的冰核蛋白在乳酸乳球菌表面展示外源蛋白的可能性.[方法]以绿色荧光蛋白(Green Fluorescence Protein,GFP)基因gfp为报告基因,以冰核蛋白基因的N末端和NC端作为展示单元,构建乳酸菌表面展示载体pHZ101和pHZ102,并转化大肠杆菌(Escherichia coli JM109和乳酸乳球菌(Lactococcus lactis)MG1363.[结果]荧光显微镜观察显示重组大肠杆菌和乳酸乳球菌均能检测到绿色荧光.Western blot结果表明GFP蛋白在重组大肠杆菌和乳酸乳球菌中均得到表达,并且INPN-GFP蛋白多数滞留于乳酸乳球菌细胞质内,而INPNC-GFP蛋白则大部分定位于乳酸乳球菌的细胞膜上.[结论]以上结果表明丁香假单胞菌的冰核蛋白能引导外源蛋白定位于乳酸乳球菌的细胞膜上,为乳酸菌表面展示系统的构建提供了新的方向.     

Kozak序列(+4G)对携带EGFP标签的人淀粉样前体蛋白751在CHO细胞中表达的影响

目的:观察Kozak序列(+4G)对稳定转染的人淀粉样前体蛋白(hAPP751)-EGFP融合真核表达载体在CHO细胞中表达的影响,为APP的水解代谢研究提供细胞模型。方法:分别将含Kozak序列(+4G)和不含Kozak序列的hAPP751全长基因片段亚克隆入pEGFP-N1表达载体,得到pEGFP-hAPP751(+4G)和pEGFP-hAPP751重组质粒,转染CHO细胞,通过G418筛选稳定转染细胞株,再用倒置荧光显微镜挑取绿色荧光强的细胞进行亚克隆,并观察融合蛋白的表达强度和细胞定位,最后用EGFP抗体通过Western印迹检测融合蛋白。结果:PCR、酶切和测序证明将含Kozak序列(+4G)和不含Kozak序列的hAPP751全长基因片段分别连入了真核表达载体pEGFP-N1中;荧光显微镜下观察pEGFP-hAPP751(+4G)稳定转染细胞的细胞膜和细胞质产生较强的绿色荧光,其中在细胞质中成不均匀颗粒状分布,Western印迹检测到相对分子质量约156 000的融合表达蛋白,与预期相符;pEGFP-hAPP751转染细胞,其绿色荧光十分微弱且在整个细胞均匀分布,Western印迹检测到相对分子质量约26 000的EGFP,但检测不到预期的hAPP751-EGFP融合表达蛋白。结论:Kozak序列(+4G)可以明显促进hAPP751的表达,获得稳定转染且高水平融合表达hAPP751-EGFP的细胞株。     

鼠李糖乳杆菌菌毛SpaA亚基的表达、抗体制备及其种属特异性研究

【目的】制备鼠李糖乳杆菌菌毛亚基Spa A多克隆抗体,研究其种属特异性。【方法】应用PCR方法从鼠李糖乳杆菌GG的基因组扩增出spa A,并连接到质粒p ET-28α(+)中。将重组质粒转化大肠杆菌BL21(DE3),经IPTG诱导表达和镍柱纯化制备重组SpaA。通过免疫BALB/c小鼠获得多克隆抗体,利用全菌ELISA、Western和Dot-blot分析了SpaA在18株乳酸菌(12个种)中的分布特征。【结果】表达的重组SpaA分子量为36 k D,与预期大小一致;获得的Spa A抗体效价为1:12 800。Western结果显示抗体与天然Spa A具有良好的反应性。在测定的18株乳酸菌中,鼠李糖乳杆菌、干酪乳杆菌、副干酪乳杆菌3个种属菌株的spa A基因PCR和RT-PCR检测均为阳性。但全菌ELISA和Dot-blot结果显示,只有3株鼠李糖乳杆菌的全菌细胞与SpaA抗体呈特异性反应,而其它种属的菌株没有明显的交叉反应。【结论】尽管spa A基因在鼠李糖乳杆菌、干酪乳杆菌、副干酪乳杆菌中具有高度同源性,但SpaA蛋白只特异性地呈现在鼠李糖乳杆菌细胞表面。本研究中获得的Spa A抗体,为高黏附性鼠李糖乳杆菌的免疫磁珠分离及菌毛功能研究提供了工具。     

乳酸乳球菌组成型表面展示载体的构建及鉴定

目的探索融合有Usp45信号肽和3Lys M锚定序列的EGFP蛋白能否通过p32启动子组成型展示于乳酸乳球菌MG1363表面。方法融合PCR法分别将p32启动子与Usp45信号肽、3Lys M与egfp基因融合亚克隆至p MD-18T载体,鉴定正确后命名为18T-p Usp45、18T-3Lys M-egfp,分别将上述片段切下依次插入p MG36e构建p MG36e-p Usp45-3Lys M-egfp。将其转化入乳酸乳球菌MG1363,荧光显微镜观察及SDSPAGE、Western-blot检测。结果成功构建重组菌p MG36e-p Usp45-3Lys M-egfp/MG1363,荧光显微镜、SDSPAGE和Western-blot检测表明重组蛋白能在MG1363中组成型表达,且分泌至胞外并锚定在细胞壁上。结论成功地构建了组成型表面展示载体p MG36e-p Usp45-3Lys M-egfp,重组蛋白能分泌至胞外且展示在MG1363细胞壁上。     

以CotC为分子载体在枯草芽孢杆菌表面展示海藻糖合酶

海藻糖是自然界中普遍存在的一种非还原性双糖,是一种极好的天然干燥剂和保鲜剂。海藻糖合酶能够催化α,α-1,4-糖苷键连接的麦芽糖直接转化为α,α-1,1-糖苷键连接的海藻糖,是生产海藻糖的首选。为获得具有良好展示效果的海藻糖合酶,将其高效稳定的展示于枯草芽孢杆菌芽孢表面,实验同时分别选取增强型绿色荧光蛋白(EGFP)和海藻糖合酶(Tres)作为模型蛋白,以来自枯草芽孢杆菌的芽孢衣壳蛋白Cot C作为枯草芽杆菌表面展示的锚定蛋白进行表面展示研究。利用流式细胞仪分析EGFP在芽孢表面展示的情况,结果表明芽孢衣壳蛋白Cot C可以将EGFP固定在芽孢的表面。然后将荧光蛋白基因egfp通过酶切替换为海藻糖合酶基因tres,将重组菌株使用p H7.5的缓冲液清洗并重悬,与底物浓度为30%的麦芽糖在50℃水浴条件下作用2h,反应产物利用HPLC检测,能够检测到海藻糖峰,通过计算得到的酶活为252U/ml。说明海藻糖合酶基因通过与芽孢衣壳蛋白Cot C融合后可被展示在芽孢的表面。     

利用荧光标记的T7噬菌体研究配体/受体的相互作用

将鸡传染性法氏囊病病毒(IBDV)衣壳蛋白VP2展示到T7噬菌体表面,以FITC标记纯化的重组噬菌体,通过荧光显微镜观察与流式细胞仪检测,研究标记噬菌体与病毒受体细胞--法氏囊B细胞的相互作用.结果展示有IBDV VP2蛋白的噬菌体经FITC标记后仍然具有与受体细胞结合的特性,荧光显微镜下可见绿色荧光,流式数据显示其平均荧光强度明显高于阴性对照,且IBDV疫苗株TAD可明显阻断其结合.由此得出结论,FITC标记与噬菌体展示技术相结合,可进行配体/受体间相互作用的研究.     

Novel surface display system for proteins on non-genetically modified gram-positive bacteria

A novel display system is described that allows highly efficient immobilization of heterologous proteins on bacterial surfaces in applications for which the use of genetically modified bacteria is less desirable. This system is based on nonliving and non-genetically modified gram-positive bacterial cells, designated gram-positive enhancer matrix (GEM) particles, which are used as substrates to bind externally added heterologous proteins by means of a high-affinity binding domain. This binding domain, the protein anchor (PA), was derived from the Lactococcus lactis peptidoglycan hydrolase AcmA. GEM particles were typically prepared from the innocuous bacterium L. lactis, and various parameters for the optimal preparation of GEM particles and binding of PA fusion proteins were determined. The versatility and flexibility of the display and delivery technology were demonstrated by investigating enzyme immobilization and nasal vaccine applications.     

Novel Surface Display System for Proteins on Non-Genetically Modified Gram-Positive Bacteria

A novel display system is described that allows highly efficient immobilization of heterologous proteins on bacterial surfaces in applications for which the use of genetically modified bacteria is less desirable. This system is based on nonliving and non-genetically modified gram-positive bacterial cells, designated gram-positive enhancer matrix (GEM) particles, which are used as substrates to bind externally added heterologous proteins by means of a high-affinity binding domain. This binding domain, the protein anchor (PA), was derived from the Lactococcus lactis peptidoglycan hydrolase AcmA. GEM particles were typically prepared from the innocuous bacterium L. lactis, and various parameters for the optimal preparation of GEM particles and binding of PA fusion proteins were determined. The versatility and flexibility of the display and delivery technology were demonstrated by investigating enzyme immobilization and nasal vaccine applications.     

Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria

Mucosal immunization with subunit vaccines requires new types of antigen delivery vehicles and adjuvants for optimal immune responses. We have developed a non-living and non-genetically modified gram-positive bacterial delivery particle (GEM) that has built-in adjuvant activity and a high loading capacity for externally added heterologous antigens that are fused to a high affinity binding domain. This binding domain, the protein anchor (PA), is derived from the Lactococcus lactis AcmA cell-wall hydrolase, and contains three repeats of a LysM-type cell-wall binding motif. Antigens are produced as antigen-PA fusions by recombinant expression systems that secrete the hybrid proteins into the culture growth medium. GEM particles are then used as affinity beads to isolate the antigen-PA fusions from the complex growth media in a one step procedure after removal of the recombinant producer cells. This procedure is also highly suitable for making multivalent vaccines. The resulting vaccines are stable at room temperature, lack recombinant DNA, and mimic pathogens by their bacterial size, surface display of antigens and adjuvant activity of the bacterial components in the GEM particles. The GEM-based vaccines do not require additional adjuvant for eliciting high levels of specific antibodies in mucosal and systemic compartments.     

Functional analysis of the p40 and p75 proteins from Lactobacillus casei BL23

The genomes of Lactobacillus casei/paracasei and Lactobacillus rhamnosus strains carry two genes encoding homologues of p40 and p75 from L. rhamnosus GG, two secreted proteins which display anti-apoptotic and cell protective effects on human intestinal epithelial cells. p40 and p75 carry cysteine, histidine-dependent aminohydrolase/peptidase (CHAP) and NLPC/P60 domains, respectively, which are characteristic of proteins with cell-wall hydrolase activity. In L. casei BL23 both proteins were secreted to the growth medium and were also located at the bacterial cell surface. The genes coding for both proteins were inactivated in this strain. Inactivation of LCABL_00230 (encoding p40) did not result in a significant difference in phenotype, whereas a mutation in LCABL_02770 (encoding p75) produced cells that formed very long chains. Purified glutathione-S-transferase (GST)-p40 and -p75 fusion proteins were able to hydrolyze the muropeptides from L. casei cell walls. Both fusions bound to mucin, collagen and to intestinal epithelial cells and, similar to L. rhamnosus GG p40, stimulated epidermal growth factor receptor phosphorylation in mouse intestine ex vivo. These results indicate that extracellular proteins belonging to the machinery of cell-wall metabolism in the closely related L. casei/paracasei-L. rhamnosus group are most likely involved in the probiotic effects described for these bacteria.     

NSOM‐ and AFM‐based nanotechnology elucidates nano‐structural and atomic‐force features of a Y. pestis V immunogen‐containing particle vaccine capable of eliciting robust response

It is postulated that unique nanoscale proteomic features of immunogen on vaccine particles may determine immunogen‐packing density, stability, specificity, and pH‐sensitivity on the vaccine particle surface and thus impact the vaccine‐elicited immune responses. To test this presumption, we employed near‐filed scanning optical microscopy (NSOM)‐ and atomic force microscopy (AFM)‐based nanotechnology to study nano‐structural and single‐molecule force bases of Yersinia pestis (Y. pestis) V immunogen fused with protein anchor (V‐PA) loaded on gram positive enhancer matrix (GEM) vaccine particles. Surprisingly, the single‐molecule sensitive NSOM revealed that ～90% of V‐PA immunogen molecules were packed as high‐density nanoclusters on GEM particle. AFM‐based single‐molecule force analyses indicated a highly stable and specific binding between V‐PA and GEM at the physiological pH. In contrast, this specific binding was mostly abrogated at the acidic pH equivalent to the biochemical pH in phagolysosomes of antigen‐presenting‐cells in which immunogen protein is processed for antigen presentation. Intranasal mucosal vaccination of mice with such immunogen loaded on vaccine particles elicited robust antigen‐specific immune response. This study indicated that high‐density, high‐stability, specific, and immunological pH‐responsive loading of immunogen nanoclusters on vaccine particles could readily be presented to the immune system for induction of strong antigen‐specific immune responses.     

Efficient and stable display of functional proteins on bacterial magnetic particles using mms13 as a novel anchor molecule

Magnetic particles are increasingly used for various biomedical applications because they are easy to handle and separate from biological samples. In this work, a novel anchor molecule was used for targeted protein display onto magnetic nanoparticles. The magnetic bacterium Magnetospirillum magneticum AMB-1 synthesizes intracellular bacterial magnetic particles (BMPs) covered with a lipid bilayer membrane. In our recent research, an integral BMP membrane protein, Mms13, was isolated and used as an anchor molecule to display functional proteins onto BMPs. The anchoring properties of Mms13 were confirmed by luciferase fusion studies. The C terminus of Mms13 was shown to be expressed on the surface of BMPs, and Mms13 was bound to magnetite directly and tightly permitting stable localization of a large protein, luciferase (61 kDa), on BMPs. Consequently, luminescence intensity obtained from BMPs using Mms13 as an anchor molecule was >400 or 1,000 times higher than Mms16 or MagA, which previously were used as anchor molecules. Furthermore, the immunoglobulin G-binding domain of protein A (ZZ) was displayed uniformly on BMPs using Mms13, and antigen was detected by transmission electron microscopy using antibody-labeled gold nanoparticles on a single BMP displaying the ZZ-antibody complex. The results of this study demonstrated the utility of Mms13 as a molecular anchor, which will facilitate the assembly of other functional proteins onto BMPs in the near feature.     

Efficient and Stable Display of Functional Proteins on Bacterial Magnetic Particles Using Mms13 as a Novel Anchor Molecule

Magnetic particles are increasingly used for various biomedical applications because they are easy to handle and separate from biological samples. In this work, a novel anchor molecule was used for targeted protein display onto magnetic nanoparticles. The magnetic bacterium Magnetospirillum magneticum AMB-1 synthesizes intracellular bacterial magnetic particles (BMPs) covered with a lipid bilayer membrane. In our recent research, an integral BMP membrane protein, Mms13, was isolated and used as an anchor molecule to display functional proteins onto BMPs. The anchoring properties of Mms13 were confirmed by luciferase fusion studies. The C terminus of Mms13 was shown to be expressed on the surface of BMPs, and Mms13 was bound to magnetite directly and tightly permitting stable localization of a large protein, luciferase (61 kDa), on BMPs. Consequently, luminescence intensity obtained from BMPs using Mms13 as an anchor molecule was >400 or 1,000 times higher than Mms16 or MagA, which previously were used as anchor molecules. Furthermore, the immunoglobulin G-binding domain of protein A (ZZ) was displayed uniformly on BMPs using Mms13, and antigen was detected by transmission electron microscopy using antibody-labeled gold nanoparticles on a single BMP displaying the ZZ-antibody complex. The results of this study demonstrated the utility of Mms13 as a molecular anchor, which will facilitate the assembly of other functional proteins onto BMPs in the near feature.     

Novel bacterial membrane surface display system using cell wall-less L-forms of Proteus mirabilis and Escherichia coli

We describe a novel membrane surface display system that allows the anchoring of foreign proteins in the cytoplasmic membrane (CM) of stable, cell wall-less L-form cells of Escherichia coli and Proteus mirabilis. The reporter protein, staphylokinase (Sak), was fused to transmembrane domains of integral membrane proteins from E. coli (lactose permease LacY, preprotein translocase SecY) and P. mirabilis (curved cell morphology protein CcmA). Both L-form strains overexpressed fusion proteins in amounts of 1 to 100 microg ml(-1), with higher expression for those with homologous anchor motifs. Various experimental approaches, e.g., cell fractionation, Percoll gradient purification, and solubilization of the CM, demonstrated that the fusion proteins are tightly bound to the CM and do not form aggregates. Trypsin digestion, as well as electron microscopy of immunogold-labeled replicas, confirmed that the protein was localized on the outside surface. The displayed Sak showed functional activity, indicating correct folding. This membrane surface display system features endotoxin-poor organisms and can provide a novel platform for numerous applications.